1037-P: Efficacy and Safety of Fast-Acting Insulin Aspart in Adults with T2D with Different Insulin Requirements

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1037-P
Author(s):  
WENDY LANE ◽  
MAGNUS EKELUND ◽  
ÓLÖF THÓRISDÓTTIR ◽  
ESTEBAN JÓDAR ◽  
ALEJANDRA OVIEDO ◽  
...  
Keyword(s):  
Insulin Aspart ◽  
Efficacy And Safety ◽  
Insulin Requirements ◽  
Acting Insulin ◽  
Fast Acting

scholarly journals Efficacy and safety of fast-acting insulin aspart versus insulin aspart in children and adolescents with type 1 diabetes from Japan

2021 ◽  
Author(s):  
Tomoyuki Kawamura ◽  
Toru Kikuchi ◽  
Hiroshi Horio ◽  
Naveen Rathor ◽  
Magnus Ekelund
Keyword(s):  
Type 1 Diabetes ◽  
Children And Adolescents ◽  
Insulin Aspart ◽  
Efficacy And Safety ◽  
Acting Insulin ◽  
Fast Acting

1034-P: Efficacy and Safety of Fast-Acting Insulin Aspart According to Baseline HbA1c in Adults with Type 2 Diabetes Treated with a Basal-Bolus Regimen

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1034-P
Author(s):  
EDWARD FRANEK ◽  
MAGNUS EKELUND ◽  
ÓLÖF THÓRISDÓTTIR ◽  
HAK CHUL JANG ◽  
KATARINA LALIC ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Aspart ◽  
Efficacy And Safety ◽  
Baseline Hba1c ◽  
Acting Insulin ◽  
Basal Bolus ◽  
Fast Acting

scholarly journals A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (ONSET 9)

Diabetes Care ◽  
2020 ◽  
Vol 43 (8) ◽  
pp. 1710-1716 ◽  
Author(s):  
Wendy S. Lane ◽  
Elena Favaro ◽  
Naveen Rathor ◽  
Hak C. Jang ◽  
Maiken I.S. Kjærsgaard ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Trial ◽  
Insulin Aspart ◽  
Insulin Degludec ◽  
Efficacy And Safety ◽  
Diabetes Onset ◽  
Acting Insulin ◽  
Fast Acting

Efficacy and Safety of Fast-acting Insulin Aspart Are Maintained over 52 weeks: Comparison with Insulin Aspart in Onset 1

2017 ◽  
Vol 41 (5) ◽  
pp. S56-S57
Author(s):  
Vincent Woo ◽  
Chantal Mathieu ◽  
Bruce Bode ◽  
Edward Franek ◽  
Athena Philis-Tsimikas ◽  
...  
Keyword(s):  
Insulin Aspart ◽  
Efficacy And Safety ◽  
Acting Insulin ◽  
Fast Acting

scholarly journals Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial

2018 ◽  
Vol 20 (12) ◽  
pp. 2885-2893 ◽  
Author(s):  
John B. Buse ◽  
Anders L. Carlson ◽  
Mitsuhisa Komatsu ◽  
Ofri Mosenzon ◽  
Ludger Rose ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Aspart ◽  
Insulin Degludec ◽  
Double Blind Trial ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Blind Trial ◽  
Acting Insulin ◽  
Fast Acting

scholarly journals Efficacy and safety of fast‐acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52‐week, randomized, treat‐to‐target, phase III trial

2018 ◽  
Vol 20 (5) ◽  
pp. 1148-1155 ◽  
Author(s):  
Chantal Mathieu ◽  
Bruce W. Bode ◽  
Edward Franek ◽  
Athena Philis‐Tsimikas ◽  
Ludger Rose ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Aspart ◽  
Phase Iii ◽  
Treat To Target ◽  
Efficacy And Safety ◽  
Phase Iii Trial ◽  
Diabetes Onset ◽  
Acting Insulin ◽  
Fast Acting

scholarly journals Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial

Diabetes Care ◽  
2019 ◽  
Vol 42 (7) ◽  
pp. 1255-1262 ◽  
Author(s):  
Bruce W. Bode ◽  
Violeta Iotova ◽  
Margarita Kovarenko ◽  
Lori M. Laffel ◽  
Paturi V. Rao ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Children And Adolescents ◽  
Insulin Aspart ◽  
Insulin Degludec ◽  
Efficacy And Safety ◽  
Acting Insulin ◽  
Fast Acting
Sign in / Sign up

Export Citation Format

Share Document